Niagen Bioscience Inc

NAGE | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.05

+$0.01 (+0.33%)

Sep 22, 2026, 10:56 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	29.79M	31.47M	33.84M	33.99M	31.12M	30.48M	29.13M	25.58M	22.74M	22.15M	21.2M	19.5M	20.32M	22.56M	21M	17.06M	16.73M	17.26M	17.76M	17.31M	17.7M	14.68M
Cost of Revenue	10.47M	11.5M	12.14M	12.06M	10.89M	11.15M	10.93M	9.34M	9.05M	8.7M	8.26M	7.53M	7.97M	9.04M	8.98M	6.86M	6.69M	6.73M	6.89M	6.73M	6.89M	5.45M
Gross Profit	19.31M	19.98M	21.7M	21.93M	20.23M	19.33M	18.2M	16.24M	13.69M	13.46M	12.94M	11.97M	12.36M	13.52M	12.02M	10.21M	10.04M	10.53M	10.87M	10.58M	10.81M	9.23M
Operating Income	700K	1.58M	2.1M	4.24M	3.19M	4.77M	7.11M	1.6M	-256K	-731K	-168K	-1.15M	-2.32M	-1.97M	-1.44M	-3.07M	-6.39M	-7.73M	-5.32M	-8.84M	-5.55M	-7.36M
Interest Income	372K	375K	552K	564K	552K	459K	373K	276K	241K	239K	282K	188K	125K	66K	26K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	1.07M	6.74M	4.42M	4.8M	3.74M	5.23M	7.48M	1.88M	-15K	-492K	114K	-959K	-2.19M	-1.9M	-1.42M	-985K	-6.4M	-7.74M	-5.33M	-8.86M	-5.57M	-7.38M
Net Income	963K	6.32M	4.13M	4.58M	3.61M	5.06M	7.18M	1.88M	-15K	-492K	114K	-959K	-2.19M	-1.9M	-1.42M	-985K	-6.4M	-7.74M	-5.33M	-8.86M	-5.57M	-7.38M
Selling & General & Admin	17.1M	16.92M	17.89M	15.9M	15.47M	13.3M	9.77M	13.35M	12.63M	12.09M	11.95M	11.88M	13.31M	14.29M	12.18M	12.05M	15.18M	17.19M	15.14M	18.42M	15.36M	15.81M
Research & Development	1.51M	1.48M	1.71M	1.8M	1.57M	1.26M	1.32M	1.29M	1.32M	2.1M	1.16M	1.24M	1.37M	1.19M	1.28M	1.22M	1.25M	1.08M	1.05M	996K	1M	787K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	18.61M	18.4M	19.6M	17.69M	17.04M	14.56M	11.09M	14.64M	13.95M	14.19M	13.11M	13.12M	14.67M	15.49M	13.46M	13.27M	16.43M	18.26M	16.18M	19.42M	16.36M	16.6M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5K	10K	8K	9K	15K	12K	19K
Selling & Marketing Expenses	10.13M	9.68M	10.41M	8.77M	8.21M	8.12M	8.72M	7.04M	6.97M	6.74M	6.52M	6.04M	6.01M	7.87M	6.19M	5.87M	8.02M	8.24M	8.64M	7.22M	6.23M	6.26M
Cost & Expenses	29.09M	29.9M	31.74M	29.75M	27.93M	25.71M	22.01M	23.98M	23M	22.88M	21.36M	20.64M	22.64M	24.52M	22.44M	20.13M	23.12M	24.99M	23.08M	26.15M	23.25M	22.05M
Income Tax Expense	106K	417K	292K	222K	128K	168K	305K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	79.32M	79.92M	78.97M	91.56M	79.25M	77.81M	76.95M	93.9M	75.56M	75.23M	72.89M	75.05M	73.03M	74.8M	73.88M	68.35M	68.34M	68.31M	68.3M	68.24M	67.99M	64.16M
Shares Outstanding (Diluted)	82.5M	84.57M	84.44M	86.62M	86.24M	83.23M	81.68M	77.77M	75.56M	75.23M	75.11M	75.05M	74.97M	74.8M	73.88M	68.35M	68.34M	68.31M	68.3M	68.24M	67.99M	64.16M
EPS (Basic)	0.01	0.08	0.05	0.06	0.05	0.07	0.09	0.02	0	-0.01	0	-0.01	-0.03	-0.03	-0.02	-0.01	-0.09	-0.11	-0.08	-0.13	-0.08	-0.12
EPS (Diluted)	0.01	0.07	0.05	0.05	0.04	0.06	0.09	0.02	0	-0.01	0	-0.01	-0.03	-0.03	-0.02	-0.01	-0.09	-0.11	-0.08	-0.13	-0.08	-0.12
EBITDA	1.17M	7.03M	5.29M	5M	4.09M	5.6M	7.84M	2.24M	355K	-102K	487K	-511K	-1.75M	-1.46M	-3.07M	-531K	-5.96M	-7.18M	-4.93M	-8.43M	-5.14M	-6.96M
EBIT	700K	6.74M	4.42M	4.8M	3.74M	5.23M	7.48M	1.88M	-15K	-492K	114K	-959K	-2.19M	-1.9M	-3.53M	-980K	-6.39M	-7.73M	-5.32M	-8.84M	-5.55M	-7.36M
Depreciation & Amortization	470K	291K	864K	195K	355K	368K	358K	366K	370K	390K	373K	448K	444K	440K	455K	449K	431K	549K	388K	416K	415K	407K